Drug
glofitamab
Marketed as COLUMVI.
Generic name
glofitamab
Brand names
COLUMVI
First FDA approval
2023-06-15
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761309 | COLUMVI | 2023-06-15 | GENENTECH INC |
Manufacturers
GENENTECH INC
Frequently asked questions
When was glofitamab FDA approved?
Earliest FDA approval on record: 2023-06-15.
What brand names are sold as glofitamab?
COLUMVI.
Sources
Appeal a glofitamab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com